Mark Kidd, Ph.D., DABCC has worked and published extensively in the area of Oncology including prostate cancer disease and is the Scientific Director of Wren Laboratories. He is also the CAP- and CLIA-certified Laboratory Director and Technical Consultant for Wren Laboratories. His professional and academic research interests have focused on the translation of molecular genomic information to biomarkers including liquid biopsies for several different solid and hematological cancers. Dr. Kidd’s publications cover diverse areas including global gene analysis, tissue microarrays, tumor biology, bacterial genetics as well as bronchopulmonary and gastroenteropancreatic pathology. Dr. Kidd has more than twenty-five years of molecular and cancer biology laboratory experience focused on oncology and other disciplines.